[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337922-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337922-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","a-druggable-cascade-links-methionine-metabolism-to-epigenomic-reprogramming-in-squamous-cell-carcinoma","A druggable cascade links methionine metabolism to epigenomic reprogramming in squamous cell carcinoma","","Upper aerodigestive squamous cell carcinoma (UASCC) is an aggressive cancer with limited effective therapies. This study shows that UASCC has the highest methionine levels among human cancers, driven by the transporter LAT1. LAT1 is transcriptionally activated in UASCC by promoter/enhancer elements co-regulated by TP63/KLF5/SREBF1, and EZH2 emerges as the key downstream target linking LAT1-methionine to epigenomic reprogramming. The resulting LAT1-methionine–EZH2 axis is required for survival and proliferation of patient-derived tumor organoids, correlates with sensitivity to axis inhibition, and can be targeted via pharmacological or dietary approaches in vivo.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/a-druggable-cascade-links-methionine-metabolism-to-epigenomic-reprogramming-in-squamous-cell-carcinoma/337922/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/a-druggable-cascade-links-methionine-metabolism-to-epigenomic-reprogramming-in-squamous-cell-carcinoma/337922.png","ImageObject",300,407,{"name":42,"@type":43},"Maeve","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What drives the elevated methionine levels in UASCC?","Question",{"text":63,"@type":64},"UASCC shows the highest methionine level across human cancers, driven by the transporter LAT1.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the LAT1-methionine pathway connect to epigenomic reprogramming?",{"text":68,"@type":64},"A bioinformatic screen identifies EZH2 as the most significant downstream target of the LAT1-methionine pathway, directly linking methionine metabolism to epigenomic reprogramming.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is the LAT1-methionine–EZH2 cascade important for UASCC, and how can it be targeted?",{"text":72,"@type":64},"The cascade is indispensable for survival and proliferation of patient-derived tumor organoids and is associated with cellular sensitivity to inhibition of the axis; it can be targeted pharmacologically or through dietary intervention in vivo.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337922,1790173322,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},5909877438554,"https://ap-avatar.wpscdn.com/avatar/5600025385ad2bf12a7?_k=1778553567797529272","A druggable cascade links methionine metabolism to epigenomic reprogramming in squamous cell carcinoma  \nChehyun Nama,1, Li-Yan Lib,c,1, Qian Yangc, Benjamin Zimana, Hua Zhaoa , Boyan Hua, Casey Colleta, Pei Jingb, Qifang Leid, Li-Yan Xub , En-Min Lib ,  \nH. Phillip Koefflerc, Uttam K. Sinhae,2, and De-Chen Lina,c,2 Affiliations are included on p. 10.  \nEdited by Stephen Baylin, Johns Hopkins University School of Medicine, Baltimore, MD; received December 4, 2023; accepted May 20, 2024  \nUpper aerodigestive squamous cell carcinoma (UASCC) is a common and aggressive malignancy with few effective therapeutic options. Here, we investigate amino acid metabolism in this cancer, surprisingly noting that UASCC exhibits the highest methionine level across all human cancers, driven by its transporter LAT1. We show that LAT1 is also expressed at the highest level in UASCC, transcriptionally activated by UASCC-specific promoter and enhancers, which are directly coregulated by SCC master regulators TP63/ KLF5/SREBF1 . Unexpectedly, unbiased bioinformatic screen identifies EZH2 as the most significant target downstream of the LAT1-methionine pathway, directly linking methionine metabolism to epigenomic reprogramming. Importantly, this cascade is indispensable for the survival and proliferation of UASCC patient-derived tumor organoids. In addition, LAT1 expression is closely associated with cellular sensitivity to inhibition of the LAT1-methionine-EZH2 axis. Notably, this unique LAT1-methionine-EZH2 cascade can be targeted effectively by either pharmacological approaches or dietary intervention in vivo. In summary, this work maps a unique mechanistic cross talk between epigenomic reprogramming with methionine metabolism, establishes its biological significance in the biology of UASCC, and identifies a unique tumor-specific vulnerability which can be exploited both pharmacologically and dietarily.  \ncancer metabolism | epigenomics | UASCC | LAT1 | methionine  \nUpper aerodigestive squamous cell carcinoma (UASCC) is an aggressive malignancy derived from stratified squamous epithelium of the upper aerodigestive tract, including oral cavity, pharynx, esophagus, etc. Over 1.5 million new cases of UASCC are diagnosed worldwide every year, with head–neck (HNSCC) and esophageal (ESCC) being the most common types (1). Despite arising from multiple different (while related) anatomical locations, UASCC and other squamous cancers, such as those from the lung (LUSC), share many genomic and epigenomic characteristics. For example, genomically, one of the most notable UASCC-specific abnormalities is copy number changes and/or somatic mutations targeting squamous cell lineage factors (e.g., TP63, SOX2, ZNF750, and NOTCH1/2/3) (2–8). Epigenomically, different types of UASCCs present similar DNA methylation profiles (9) as well as histone modification landscapes (10, 11) .  \nEffective targeted regimens are still unavailable for most UASCC, which is highly aggressive. For example, the 5-y survival rate of ESCC patients is between 20% and 30%  \n(12). Conventional cytotoxic radio-and chemo-therapeutic options for UASCC patients are limited and often ineffective. Clearly, an urgent need exists to better understand the pathophysiology of UASCC to advance the health care and life quality of its patients.  \nMetabolic reprogramming is a cancer hallmark (13). An emerging but significant aspect of cancer metabolism is the deregulated methionine cycle, which has been documented to be elevated in cancer and required for cancer cell fitness (14) . More specifically, cancer cells exhibit heightened dependency on exogenous methionine, which was initially speculated to be caused by defects in methionine synthesis endogenously (15) . However, further investigations showed that tumor cells synthesized methionine at rates comparable with those in nonmalignant cells (15) . Importantly, the amount of methionine obtained from the diet has an immediate and substantial effect on the","cbCaie92Cu4T3F7j","https://ap.wps.com/l/cbCaie92Cu4T3F7j","pdf",12450618,11,"English","# Significance\n## LAT1-methionine–EZH2 mechanistic cascade\n## Therapeutic vulnerability via pharmacological or dietary targeting","[{\"question\":\"What drives the elevated methionine levels in UASCC?\",\"answer\":\"UASCC shows the highest methionine level across human cancers, driven by the transporter LAT1.\"},{\"question\":\"How does the LAT1-methionine pathway connect to epigenomic reprogramming?\",\"answer\":\"A bioinformatic screen identifies EZH2 as the most significant downstream target of the LAT1-methionine pathway, directly linking methionine metabolism to epigenomic reprogramming.\"},{\"question\":\"Why is the LAT1-methionine–EZH2 cascade important for UASCC, and how can it be targeted?\",\"answer\":\"The cascade is indispensable for survival and proliferation of patient-derived tumor organoids and is associated with cellular sensitivity to inhibition of the axis; it can be targeted pharmacologically or through dietary intervention in vivo.\"}]","A druggable cascade links methionine metabolism to epigenomic reprogramming in squamous cell carcinoma | PDF",1790021183,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f4c599f36fa8c303f5b863c4d46e992b.webp",983,1316,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b8932cda3a67c527e2a371885313988b.webp",982,1315,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2ea2088320a8ce476e4f0928f668febe.webp",981,1313,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1d9adf2cb8b2c206cdd5c7b418cf55f3.webp",980,1312]